HOME >> MEDICINE >> NEWS
NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks

The National Institute of Allergy and Infectious Diseases (NIAID) today announced the clinical investigators and institutions that will lead NIAID's newly restructured HIV/AIDS clinical trials networks in the search for safe and effective treatments and prevention strategies, including HIV vaccines. NIAID, part of the National Institutes of Health (NIH), supports the world's largest portfolio of clinical HIV/AIDS research.

"The new network structure expands our clinical research capacity and strengthens our ability to take advantage of emerging scientific opportunities," says NIAID Director Anthony S. Fauci, M.D. "By creating a more integrated, collaborative and flexible structure, we will be better equipped to meet evolving global AIDS research priorities."

These leadership group awards represent the first step of the two-part restructuring process of the HIV/AIDS clinical trials networks. Awards for the Clinical Trials Units (CTUs), which will carry out the clinical research, are expected to be announced later this year.

Each leadership group will be led by a principal investigator and include a core operations group that will provide administrative and technical support; a statistical and data management center; and a network laboratory structure. The following principal investigators and institutions will lead the newly restructured HIV/AIDS networks:

  • AIDS Clinical Trials Group (ACTG)--Constance A. Benson, M.D., University of California, San Diego
  • HIV Prevention Trials Network (HPTN)--Sten Vermund, M.D., Ph.D., Vanderbilt University, Nashville
  • HIV Vaccine Trials Network (HVTN)--Lawrence Corey, M.D., The Fred Hutchinson Cancer Research Center, Seattle
  • International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)--Jay Brooks Jackson, M.D., Johns Hopkins University School of Medicine, Baltimore
  • Interna
    '"/>


Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
29-Jun-2006


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2018)... ... August 31, 2018 , ... Alice Branton shared her personal story ... issues with Daytime host Jerry Penacoli. , With all the medical advancements over ... deficiency is a major public health problem worldwide irrespective of age, location, ethnicity, and ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... an Open House on Wednesday, September 12 from 1:00-3:00 pm. MedMark ... Rapids, as well as tour the facility, meet our staff and learn more ...
(Date:8/31/2018)... Pa. (PRWEB) , ... August 31, 2018 , ... ... those offered by the American Heart Association (AHA) to be responsive for procurement ... concerns and purchasing managers may now reap the benefits. Companies like Pacific Medical ...
(Date:8/31/2018)... SCOTCH PLAINS, N.J. (PRWEB) , ... August 31, ... ... gastroenterologist, Dr. Joseph Savon of South Jersey Gastroenterology for another year. Dr. Savon ... has been one of the leaders in comprehensive care for all gastrointestinal diseases ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... Inc.’s “hit” list. The company, a small molecule drug discovery and development ... September 2017 with a mission to develop a first-in-class therapeutic targeting rare ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... ... "As of Thursday, Sept. 13, 2018, Cedar Point, North Carolina, where I ... Women of Influence tour with the knowledge that my home will have some repairs ... onto my faith through this storm. So many lives are being affected by flood ...
(Date:9/13/2018)... ... September 13, 2018 , ... This September is ... campaign is designed to raise awareness on how to help prevent food poisoning. According ... people) get sick, 128,000 are hospitalized, and 3,000 die from eating contaminated food. In ...
(Date:9/13/2018)... ... 13, 2018 , ... AccentCare, Inc., a nationwide leader in ... regional Texas Home Health operations the largest Texas-based post-acute care provider offering ... care services. , Texas Home Health operations serve all 254 counties in Texas, ...
Breaking Medicine Technology:
Cached News: